Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit"
Int. braz. j. urol; 43 (2), 2017
Publication year: 2017
ABSTRACT Background Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. Objective Using zonal volumes and asymmetry of glandular acini, we generate a peripheral zone acinar volume and density. With the ratio to the whole gland, we can better predict high grade and all grade cancer. We can model the gland into its acinar and stromal elements. This new “prostatocrit” model could offer more accurate nomograms for biopsy. Materials and Methods 674 patients underwent TRUS and biopsy. Whole gland and zonal volumes were recorded. We compared ratio and acinar volumes when added to a “clinic” model using traditional PSA density. Univariate logistic regression was used to find significant predictors for all and high grade cancer. Backwards multiple logistic regression was used to generate ROC curves comparing the new model to conventional density and PSA alone.
Outcome and results Prediction of all grades of prostate cancer:
significant variables revealed four significant “prostatocrit” parameters: log peripheral zone acinar density; peripheral zone acinar volume/whole gland acinar volume; peripheral zone acinar density/whole gland volume; peripheral zone acinar density. Acinar model (AUC 0.774), clinic model (AUC 0.745) (P=0.0105).Prediction of high grade prostate cancer:
peripheral zone acinar density (“prostatocrit”) was the only significant density predictor. Acinar model (AUC 0.811), clinic model (AUC 0.769) (P=0.0005). Conclusion There is renewed use for ratio and “prostatocrit” density of the peripheral zone in predicting cancer. This outperforms all traditional density measurements.
Células Acinares/patología, Biopsia, Modelos Logísticos, Persona de Mediana Edad, Clasificación del Tumor, Valor Predictivo de las Pruebas, Próstata/patología, Antígeno Prostático Específico/sangre, Neoplasias de la Próstata/sangre, Neoplasias de la Próstata/patología, Curva ROC, Estándares de Referencia, Reproducibilidad de los Resultados, Células del Estroma